| Product Code: ETC10981429 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Latvia`s veterinary CRO CDMO import market in 2024 saw continued strong growth, with Lithuania, Poland, Germany, Czechia, and the Netherlands emerging as top exporting countries. The high concentration in the market, as indicated by the HHI, signifies a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was impressive at 10.32%, showcasing sustained expansion. Moreover, the growth rate from 2023 to 2024 stood at 6.16%, highlighting the market`s resilience and attractiveness for both domestic and international players.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Veterinary CRO CDMO Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Veterinary CRO CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Veterinary CRO CDMO Market - Industry Life Cycle |
3.4 Latvia Veterinary CRO CDMO Market - Porter's Five Forces |
3.5 Latvia Veterinary CRO CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Latvia Veterinary CRO CDMO Market Revenues & Volume Share, By Drug Development Stage, 2021 & 2031F |
3.7 Latvia Veterinary CRO CDMO Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
3.8 Latvia Veterinary CRO CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Latvia Veterinary CRO CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Latvia Veterinary CRO CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for specialized veterinary medicines and services |
4.2.2 Growing trend towards outsourcing of drug manufacturing by veterinary companies |
4.2.3 Rising focus on research and development in veterinary medicine sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for veterinary drug manufacturing |
4.3.2 Limited availability of skilled workforce in veterinary CRO and CDMO sector |
4.3.3 Competition from established players in the market |
5 Latvia Veterinary CRO CDMO Market Trends |
6 Latvia Veterinary CRO CDMO Market, By Types |
6.1 Latvia Veterinary CRO CDMO Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Veterinary CRO CDMO Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Latvia Veterinary CRO CDMO Market Revenues & Volume, By Contract Research, 2021 - 2031F |
6.1.4 Latvia Veterinary CRO CDMO Market Revenues & Volume, By Contract Manufacturing, 2021 - 2031F |
6.2 Latvia Veterinary CRO CDMO Market, By Drug Development Stage |
6.2.1 Overview and Analysis |
6.2.2 Latvia Veterinary CRO CDMO Market Revenues & Volume, By Preclinical, 2021 - 2031F |
6.2.3 Latvia Veterinary CRO CDMO Market Revenues & Volume, By Commercialization, 2021 - 2031F |
6.3 Latvia Veterinary CRO CDMO Market, By Animal Type |
6.3.1 Overview and Analysis |
6.3.2 Latvia Veterinary CRO CDMO Market Revenues & Volume, By Companion Animals, 2021 - 2031F |
6.3.3 Latvia Veterinary CRO CDMO Market Revenues & Volume, By Livestock, 2021 - 2031F |
6.4 Latvia Veterinary CRO CDMO Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Latvia Veterinary CRO CDMO Market Revenues & Volume, By Drug Testing, 2021 - 2031F |
6.4.3 Latvia Veterinary CRO CDMO Market Revenues & Volume, By Vaccine Production, 2021 - 2031F |
6.5 Latvia Veterinary CRO CDMO Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Latvia Veterinary CRO CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5.3 Latvia Veterinary CRO CDMO Market Revenues & Volume, By Biotech Firms, 2021 - 2031F |
7 Latvia Veterinary CRO CDMO Market Import-Export Trade Statistics |
7.1 Latvia Veterinary CRO CDMO Market Export to Major Countries |
7.2 Latvia Veterinary CRO CDMO Market Imports from Major Countries |
8 Latvia Veterinary CRO CDMO Market Key Performance Indicators |
8.1 Percentage increase in number of veterinary drug development projects outsourced to CRO/CDMOs |
8.2 Average turnaround time for new drug development projects in the veterinary CRO/CDMO market |
8.3 Number of collaborations and partnerships between veterinary companies and CRO/CDMO service providers |
9 Latvia Veterinary CRO CDMO Market - Opportunity Assessment |
9.1 Latvia Veterinary CRO CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Latvia Veterinary CRO CDMO Market Opportunity Assessment, By Drug Development Stage, 2021 & 2031F |
9.3 Latvia Veterinary CRO CDMO Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
9.4 Latvia Veterinary CRO CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Latvia Veterinary CRO CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Latvia Veterinary CRO CDMO Market - Competitive Landscape |
10.1 Latvia Veterinary CRO CDMO Market Revenue Share, By Companies, 2024 |
10.2 Latvia Veterinary CRO CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |